Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Target ranges
Target ranges for other psychotropics
Temazepam concentration in normal dosing and UK legal limit use in patients with hepatic impairment use in patients with renal impairment
Teratogenic potential antidepressants carbamazepine first generation antipsychotics mood stabilisers (eg valproate) 714 second generation antipsychotics topiramate use in patients with hepatic impairment use in patients with renal impairment valproate withdrawal effects
Teratogenic risk
Test doses, long-acting injectable antipsychotics
Testosterone in blood, psychotropic agent effects
Tetrabenazine
The advantages and disadvantages of medications indicated for treating ADHD in adults
The alcohol-disulfiram reaction
The human sexual response
Theophylline, safety in older patients/dementia
The pharmacological management of premenstrual dysphoric disorder.
Therapeutic threshold
The risk of recurrence in patients who have several episodes of depression.
The use of lithium with clozapine.
thiamine (vitamin B1) injections, alcohol withdrawal adjunctive treatment
thiamine deficiency (Wernickeâ™s encephalopathy), alcohol dependency
thiamine for Wernickeâ™s encephalopathy in alcohol dependency
Thiazide diuretics, lithium interaction
Thrombocytopenia 22q11.2 deletion syndrome Clozapine: uncommon or unusual adverse effects Drug choice in breastfeeding Valproate
Thromboembolism Clozapine: serious cardiovascular adverse effects Clozapine: uncommon or unusual adverse effects Menopause Venous thromboembolism
Thyroid adverse effects, lithium
Thyroid function tests, antipsychotic medication monitoring
Thyroid-stimulating hormone, psychotropic agent effects
Thyroxine in blood, psychotropic agent effects
tics and Touretteâ™s syndrome antipsychotics pharmacological treatments
Timing of withdrawal symptoms of different opioids
Titration schedules Clozapine initiation schedules Initiation of clozapine in the community
Tolerance, dependence syndrome